| BRAF mutated colorectal cancer: New treatment approaches J Molina-Cerrillo, M San Román, J Pozas, T Alonso-Gordoa, M Pozas, ... Cancers 12 (6), 1571, 2020 | 67 | 2020 |
| Tyrosine kinase receptors in oncology J Esteban-Villarrubia, JJ Soto-Castillo, J Pozas, M San Román-Gil, ... International journal of molecular sciences 21 (22), 8529, 2020 | 63 | 2020 |
| Molecular mechanisms of resistance to immunotherapy and antiangiogenic treatments in clear cell renal cell carcinoma PÁ Ballesteros, J Chamorro, MS Román-Gil, J Pozas, ... Cancers 13 (23), 5981, 2021 | 32 | 2021 |
| Targeting angiogenesis in pancreatic neuroendocrine tumors: resistance mechanisms J Pozas, M San Román, T Alonso-Gordoa, M Pozas, L Caracuel, ... International journal of molecular sciences 20 (19), 4949, 2019 | 22 | 2019 |
| Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies M San Roman-Gil, J Pozas, D Rosero-Rodriguez, J Chamorro-Perez, ... Cancer treatment reviews 105, 102372, 2022 | 15 | 2022 |
| Receptor tyrosine kinase inhibitors for the treatment of recurrent and unresectable bone sarcomas V Albarrán, ML Villamayor, J Chamorro, DI Rosero, J Pozas, ... International Journal of Molecular Sciences 23 (22), 13784, 2022 | 13 | 2022 |
| Her-2 targeted therapy in advanced urothelial cancer: from monoclonal antibodies to antibody-drug conjugates V Albarrán, DI Rosero, J Chamorro, J Pozas, M San Román, AM Barrill, ... International Journal of Molecular Sciences 23 (20), 12659, 2022 | 11 | 2022 |
| Current Landscape of Immunotherapy for Advanced Sarcoma V Albarrán, ML Villamayor, J Pozas, J Chamorro, DI Rosero, ... Cancers 15 (8), 2287, 2023 | 7 | 2023 |
| Current landscape and potential challenges of immune checkpoint inhibitors in microsatellite stable metastatic colorectal carcinoma M San-Román-Gil, J Torres-Jiménez, J Pozas, J Esteban-Villarrubia, ... Cancers 15 (3), 863, 2023 | 7 | 2023 |
| Novel tyrosine kinase targets in urothelial carcinoma J Torres-Jiménez, V Albarrán-Fernández, J Pozas, MS Román-Gil, ... International Journal of Molecular Sciences 22 (2), 747, 2021 | 7 | 2021 |
| Androgen receptor signaling inhibition in advanced castration resistance prostate cancer: what is expected for the near future? J Pozas, S Álvarez Rodríguez, VA Fernández, J Burgos, M Santoni, ... Cancers 14 (24), 6071, 2022 | 6 | 2022 |
| Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: A case report and review of literature V Albarrán, J Pozas, F Rodríguez, Á Carrasco, E Corral, Y Lage, ... Translational Lung Cancer Research 10 (7), 3303, 2021 | 6 | 2021 |
| Current and future role of tyrosine kinases inhibition in thyroid cancer: from biology to therapy M San Román Gil, J Pozas, J Molina-Cerrillo, J Gómez, H Pian, M Pozas, ... International Journal of Molecular Sciences 21 (14), 4951, 2020 | 6 | 2020 |
| Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations J Pozas, T Alonso-Gordoa, M San Román, M Santoni, C Thirlwell, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (5), 188804, 2022 | 4 | 2022 |
| Epigenetics in advanced renal cell carcinoma: Potential new targets J Molina-Cerrillo, M Santoni, Á Ruiz, F Massari, J Pozas, I Ortego, ... Critical Reviews in Oncology/Hematology 180, 103857, 2022 | 3 | 2022 |
| Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report J Pozas, V Albarrán-Fernández, L González-Campo, ME Olmedo-García, ... Translational Lung Cancer Research 11 (7), 1497, 2022 | 3 | 2022 |
| Adoptive T cell therapy for solid tumors: current landscape and future challenges V Albarrán, M San Román, J Pozas, J Chamorro, DI Rosero, P Guerrero, ... Frontiers in Immunology 15, 1352805, 2024 | | 2024 |
| Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature M San-Román-Gil, I Martínez-Delfrade, V Albarrán-Fernández, ... Frontiers in Immunology 15, 1352262, 2024 | | 2024 |
| Identifying prognostic factors in patients with radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) treated with tyrosine kinase inhibitors (TKI): Data from … MV San Roman Gil, J Hernando, A R Granados, A Carmona, ... ANNALS OF ONCOLOGY 34, S1146-S1146, 2023 | | 2023 |
| P-115 Cytoreductive surgery and HIPEC in the treatment of peritoneal carcinomatosis: The experience in a tertiary university hospital JC Perez, DR Rodríguez, PR Puertas, M Delfrade, RF Mateos, F Longo, ... Annals of Oncology 34, S55, 2023 | | 2023 |
